IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes

Scandinavian Journal of Immunology

Volumn 46, Issue 1, 1997, Pages 96-102

  Rezende, S A ^a   Silva Teixeira, D N ^a   Drummond, S C ^b   Goes, A M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GRANULOMATOUS INFLAMMATION; HUMAN; HYPERSENSITIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0030741963     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-92.x     Document Type: Article

References (28)

1. Boros DL. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 1989;2:250-80.
2. Pearce EJ, Caspar P, Grzych J, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991;173: 159-66.
3. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Cause WC, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993;151:1430-40.
4. Colley DG. Immune responses and immunoregulation in experimental and clinical schistosomiasis. In: Mansfield JM. ed. Recent Advances in Clinical Immunology. London: Marcel Decker Inc. 1987:1-83.
5. Flores-Villanueva PO, Chikinguwo SM, Harris TS, Stadecker MJ. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J Immunol 1993;151:3192-7.
6. Moore KW, O'Garra A, de Waal De Malefyt R, Vieira P, Mosmann TR. Interleukin 10. Annu Rev Immunol 1993;11:165-81.
7. Flores-Villanueva PO, Zheng XX, Strom TB, Stadecker MJ. Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J Immunol 1996;156:3315-20.
8. Joseph AL, Boros DL. Tumor necrosis plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J Immunol 1993;151:5461-71.
9. Flores-Villanueva PO, Harris TLS, Ricklan DE, Stadecker MJ. Accessory cell signals regulate Th-cell responses: from basic immunology to a model of helminthic disease. J Immunol 1994;152:571-5.
10. Montesano MA, Lima MS, Correa-Oliveira R, Gazzinelli G, Colley DG. Immune responses during human schistosomiasis mansoni. Idiotypic differences in antibody preparations from patients with different clinical forms of infection. J Immunol 1989;142:2501-5.
11. Goes AM, Gazzinelli G, Rocha R, Katz N, Doughty BL. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. III. In vitro granuloma modulation induced by immune complexes. Am J Trop Med Hyg 1991;4:434-43.
12. Goes AM, Rezende SA, Gazzinelli G, Doughty BL. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. IV. A role for prostaglandin induced inhibition of in vitro granuloma formation. Parasite Immunol 1994;16:11-18.
13. Rezende SA, Miranda TCL, Ferreira MG, Goes AM. In vitro granuloma modulation induced by immune complexes in human schistosomiasis mansoni. Braz J Med Biol Res 1993;26:207-11.
14. Greco DB, Pedroso ER, Lambertucci JR et al. Pulmonary involvement in schistosomiasis mansoni. Mem Inst Oswaldo Cruz 1987; 82:221-7.
15. Sobh M, Moustafa FE, Sally SM, Deelder AM, Ghoneim MA. Characterization of kidney lesions in early schistosomal-spocific nephopathy. Nephron Dial Transplant 1988;59:392-8.
16. Bebars MA, Soffar SA, Abbas MM, Ismail MS, Tamara FA. Circulating immune complex in bilharzial arthropathy. J Egypt Soc Parasitol 1992;22:51-7.
17. Butterworth AE, Remold VH, David JR, Franks D, David PH, Sturrock RF. Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. J Immunol 1977;37:2230-6.
18. Kamal KA, Higashi GI. Suppression of mitogen-induced lymphocyte transformation by plasma from patients with hepatosplenic schistosomiasis mansoni: role of immune complexes. Parasite Immunol 1982;4:283-98.
19. Doughty BL, Goes AM, Parra JC et al. Granulomatous hypersensitivity to Schistosoma mansoni egg antigen in human schistosomiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads. Mem Inst Oswaldo Cruz 1987;82:47-54.
20. Katz N, Chaves A. Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 1972;14:397-400.
21. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976;72:327-31.
22. Luckas NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL. Inflammatory granuloma formation is mediated hy TNF-α-inducible intercellular adhesion molecule-1. J Immunol 1994;152: 5883-9.
23. Oster WA, Lindenmann SH, Horn S, Mertelsmann R, Herrmann F. Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 1987;70:1700-5.
24. Munker R, Gasson J, Ogawa M, Koeffler HP. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 1986;323:79-82.
25. Zwingenberger K, Irschick E, Vergetti Siqueira JG, Correira Dacal AR. Feldmeir H. Tumor necrosis factor in hepatosplenic schistosomiasis. Scand J Immunol 1990;31:205-10.
26. Henderson GS, Lu X, McCurley M, Colley DG. In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-γ mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spleens during the course of modulation. J Immunol 1992;148:2261-9.
27. 2 inhibits TNF-α release via a mechanism involving IL-10. J Immunol 1995;154:3383-90.
28. 2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995;181:775-80.